#SkinnyTok banned: A look a viral weight loss hacks on TikTok and why you should avoid them
Scrolling through social media quite often lands users on videos featuring people gushing about their weight loss journeys. This has become a highly popular trend, and people look forward to trying out these hacks to shed some extra kilos. However, these trends more often than not pose health risks. TikTok has banned #SkinnyTok
According to USA Today, TikTok recently put a ban on the hashtag #SkinnyTok after multiple warnings and public outrage regarding the trend promotion of highly dangerous body standards and extreme weight loss.
This hasn't happened for the first time. In September last year, Liv Schmidt got banned after building her platform around weight loss and thinness.
From #SkinnyTok to extreme diet challenges, social media platforms, such as TikTok, are filled with millions of videos centered around health and wellness.
Viewed by a large number of users, these videos boast about how people can shed weight in less amount of time. What remains concerning is that such trends fail to have any scientific backing and often can end up posing serious health risks to individuals.
Also read: Influencer Erika Cramer's Instagram account suspended due to shocking reason: 'I've been accused...' Popular weight loss hacks on TikTok Ozempic medication
Although a diabetes medication, Ozempic is misused by individuals and promoted as a fast weight-loss solution. But experts suggest that it can ultimately lead to serious side effects, such as nausea, pancreatitis, and thyroid tumors, according to digital magazine Sugbo.ph. Coffee and lemonade
Having a mix of coffee and lemon juice can help in suppressing appetite, according to some social media influencers. However, they fail to inform their fans that it can ultimately lead to dehydration and even stomach ulcers in some cases. Rice water detox
Another popular health trend advises consuming rice water as a metabolism booster. This is being promoted without any scientific evidence supporting the claim. Extreme fasting
Fasting for longer periods can result in muscle loss and deficiency of nutrients in the body, according to experts. FAQs: 1. Does Ozempic help in weight loss?
According to the Cleveland Clinic, taking Ozempic or similar medications makes more GLP-1 in the body, which decreases appetite and makes people feel fuller. 2. What is #SkinnyTok?
This was a popular hashtag on TikTok, which promoted content which advises people on how to be skinnier. 3. What's the best method for weight loss?
There are several authentic ways advised by experts to lose weight, with sustainable lifestyle changes being a key focus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
32 minutes ago
- News18
Indian CEO's ‘Your Heart Isn't A Machine' Post From Hospital Bed Backfires
Harsh Macwan took to Instagram and shared a picture of himself from the hospital bed, which left the internet divided. Recent years have witnessed a significant rise in heart attack cases, particularly among younger adults. Several factors have contributed to this increase, including lifestyle changes, stress, a poor diet, and a lack of exercise. An Indian CEO recently shed light on such health scares, sharing the near-cardiac incident that left him highly concerned. Harsh Macwan, an IIM Ahmedabad alumnus, recently took to Instagram and shared how he recently 'came dangerously close to something" that led him to the hospital in just a few minutes. In what appears to be an attempt to caution fellow users about the health scare associated with today's fast-paced life, it eventually didn't sit well with everyone. Macwan shared his post, which featured a picture of himself in the hospital bed, now going viral for all the wrong reasons. 'It started with a sharp, crushing pressure in my chest. My left arm went numb. I was breathless, sweating, and disoriented. Within minutes, I was rushed to the hospital. What followed were ECGs and constant monitoring. I've always been the type to push through deadlines, fatigue, and stress. But this time, my body said enough," the CEO wrote in the caption. Further in the post, he urged young founders and leaders to prioritise their health over any startup, client, or ambition. 'Your heart isn't a machine. Take that day off. Sleep. Walk. Switch off your phone. Because when your body gives you a final warning, you won't get to reschedule it," he continued. While Macwan expressed that he is currently recovering, his post received warm reactions on the handle. Many of his followers expressed concern, asking him to take care and get proper rest. One wrote, 'Sending good vibes. Take care," while another added, 'Rightly said… Take care and proper rest." 'Feel better soon," another comment read. On the contrary, the post also grabbed the attention of a Reddit user who reshared the picture and took a jibe with, 'Take a pic, I'm going to post about this to help other founders – Heart Attack LinkedIn Survivor." Further in his post, the user described it as a 'haul of fame of craziest posts," asking people to save themselves. Many others also resonated with the remark, as they too joined in to call out the sharing of the picture. One wrote, 'No, no, take another picture—I don't look pathetic enough yet!!" while another added, 'Cannot wait to have a heart attack to post it on LinkedIn! So exciting!!!" 'The weird thing here is a posed hospital selfie. He's not the only guilty one – but unless it's a posed 'I just gave birth and this is our first family photo" then it's odd. Hope the dude is on the mend now," a user continued. Nonetheless, amid the criticism and well-wishes, the CEO's post does draw attention to the need for working professionals to focus on their lifestyle and health concerns.
India Today
an hour ago
- India Today
Endocrinologist Dr. Ambrish Mithal on the happy side-effects of weight-loss drugs
New-age weight-loss drugs are exploding the pharmaceutical market, offering better results than traditional medicines. Top endocrinologist Dr. Ambrish Mithal deconstructs the many facets, including side-effects, of these GLP-1 drugs in his recently published book The Weight Loss Revolution, in an episode of India Today's said that while the GLP-1 field -- drugs that belong to the class of GLP-1 targeting the same hormone in the body -- is just beginning to explode, there'll be many newer drugs with less and less side effects and easier to most cases have shown muscle loss as a prominent result of using GLP-1 medications like tirzepatide or semaglutide, Dr. Mithal explains that losing muscle is an accompanying factor to weight loss. "In the long run, if you're not following a healthy diet, you will end up with significant muscle loss. And this is not because of the weight-loss drugs. Whenever we lose weight, we also lose muscle. If you lose 10 kg, you've lost 2-3 kg of muscle. Now, if you want to preserve that, you have to ensure adequate protein and fibre in your diet. Along with that, you have to make sure that you're exercising regularly and that exercise should include strength training," Dr. Mithal also shared what many people experience loose skin after taking these medicines. "When you lose weight rapidly, you lose subcutaneous fat. Particularly in older people where skin tends to sag anyway. If you suddenly lose weight, don't hydrate yourself well, not eating the right kind of balanced diet, then you get that little sagging on the face which people have started calling Ozempic face. Before these drugs came into the market, anyone we put on a very strict diet or someone who had bariatric surgery would see similar results," he gastrointestinal side-effects, nausea, and vomiting, Dr. Mithal addressed concerns about thyroid cancer, highlighting that there's no evidence to link the also explained the "happy side-effects" of GLP-1 medications. Besides growing body of evidence suggesting how semaglutide is linked to Alzheimer's disease, Dr. Mithal said that the benefits of the drugs are moving beyond weight loss."The evidence that they might be helping Alzheimer's by helping obesity in the brain may actually be very exciting, and even for cardiac health, Parkinson's disease. Cardiac events are reduced. Fatty liver is reduced. Kidney disease progression is reduced. But the brain effects are particularly fascinating. Sleep apnea has also gone down," he said, adding that the drugs have also helped improve fertility outcomes in women with PCOS (Polycystic Ovary Syndrome).Currently, most GLP-1 drugs are injectable and expensive, limiting their access in India. However, new formulations and more research are on the way. Novo Nordisk's Wegovy and Eli Lilly's Mounjaro, two blockbuster fat-busting medicines, are set to gain ground in India to tackle the diabetes and obesity crisis."Remember, the GLP-1 field is just beginning to explode. There'll be many newer drugs with less and less side effects and easier to use," Dr. Mithal sayssaid.- EndsMust Watch
Hindustan Times
an hour ago
- Hindustan Times
New weight-loss drug Wegovy is here, but is it a magical solution? Experts weigh in
The obsession with weight loss injections is still going strong. After the social media frenzy around Ozempic last year and celebrities such as Meghan Trainor, Lizzo, and Amy Schumer admitting to using it, and the buzz when Mounjaro (Elon Musk revealed he used it too!) arrived in India this March, there's a new contender on the block: Wegovy. Earlier this week (June 24), Danish pharmaceutical giant Novo Nordisk launched this much-anticipated drug in India. But what makes it different from its predecessors, and why is everyone talking about it? Wegovy is designed for long-term weight management and to help reduce the risk of serious cardiovascular events in people living with obesity. It comes in a sleek, once-weekly pen device with five dosing options: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and a maintenance dose of 2.4 mg. New weight-loss drug Wegovy is here, but is it a magical solution? Experts weigh in(Photo: Adobe Stock) Similar to Ozempic and Mounjaro, this new weight loss drug is also a prescription-only medication intended for adults who are obese or overweight and also have at least one weight-related health condition, like high blood pressure, type 2 diabetes, or high cholesterol. 'The active ingredient in Wegovy is semaglutide, which is a synthetic version of a naturally occurring hormone called GLP-1 (glucagon-like peptide-1). This hormone is released in the gut in response to food intake and helps regulate appetite and food intake,' informs Dr Kashish Gupta, Consultant Endocrinology at PSRI Hospital. In essence, semaglutide helps you feel full sooner, slows digestion and reduces hunger. These effects can lead to reduced calorie intake over time and, eventually, weight loss. It may also improve blood sugar levels and help lower the risk of heart issues in certain individuals, particularly those with type 2 diabetes. Who can use it? According to Dr Anjana Kalia, a dietitian at Diet Clinix, it's intended for adults with a Body Mass Index (BMI) of 30 or above, or 27 and above if there's a related health issue. 'But these are not miracle solutions. The decision to use it should always be taken with a qualified doctor after assessing medical history and risks,' she cautions. Who should avoid it? People who have a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome, have had pancreatitis or severe digestive disorders, are pregnant, breastfeeding or planning to conceive, have eating disorders, or are allergic to semaglutide or its components. These drugs should be taken in full consultation with your medical practitioner. Wegovy vs Mounjaro vs Ozempic 1. Wegovy Active ingredient: Semaglutide Approved for: Weight loss Dosage: Once weekly Benefits: Helps regulate blood sugar levels, lowers the risk of cardiovascular events Side effects: Nausea, diarrhoea, vomiting Price: ₹ 17,345 a month for 0.25mg, 0.5mg, and 1mg doses and ₹ 24,280 and ₹ 26,050 a month for 1.7mg and 2.4mg doses, respectively. 2. Mounjaro Active ingredient: Tirzepatide Approved for: Type 2 diabetes Dosage: Once weekly Benefits: Helps regulate blood sugar levels, improves insulin sensitivity Side effects: Nausea, diarrhoea, vomiting and pancreatitis or thyroid issues in rare cases Price: ₹ 4,375 ($50.67) for a 5 mg vial, ₹ 3,500 ($40.54) for a 2.5mg vial. 3. Ozempic Active ingredient: Semaglutide Approved for: Type 2 diabetes Dosage: Once weekly Benefits: Helps regulate blood sugar levels, decreases appetite Side effects: Nausea, diarrhoea, upset stomach Price: The injectable Ozempic can cost between ₹ 8,000 and ₹ 20,000 a shot.
